Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: Evaluation using two-and three-dimensional optical coherence tomography

EuroIntervention

Volumn 11, Issue 8, 2015, Pages 877-884

  Grundeken, Maik J ^a   Hassell, M ^a   Kraak, Robin P ^a   De Bruin, Daniël M ^a   Koch, Karel T ^a   Henriques, Jose P S ^a   Van Leeuwen, Ton G ^a   Tijssen, Jan G P ^a   Piek, Jan J ^a   De Winter, Robbert J ^a   Wykrzykowska, Joanna J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Coronary artery disease; Coronary bifurcations; Optical coherence tomography

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BIORESORBABLE SCAFFOLD; CLINICAL ARTICLE; CORONARY ARTERY RECANALIZATION; CORONARY BIFURCATION LESION; CORONARY STENT; CORONARY STENTING; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PERCUTANEOUS CORONARY INTERVENTION; THREE DIMENSIONAL OPTICAL COHERENCE TOMOGRAPHY; TREATMENT OUTCOME; TWO DIMENSIONAL OPTICAL COHERENCE TOMOGRAPHY; ADVERSE EFFECTS; BIODEGRADABLE IMPLANT; COMPUTER ASSISTED DIAGNOSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DEVICES; FEMALE; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSTHESIS DESIGN; RADIOGRAPHY; STENT; THREE DIMENSIONAL IMAGING; TIME FACTOR;

ABSORBABLE IMPLANTS; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84954234192     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY14M08_15     Document Type: Article

References (23)

1. Brar SS, Gray WA, Dangas G, Leon MB, Aharonian VJ, Brar SK, Moses JW. Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials. EuroIntervention. 2009;5:475-84.
2. Hildick-Smith D, Lassen JF, Albiero R, Lefevre T, Darremont O, Pan M, Ferenc M, Stankovic G, Louvard Y; European Bifurcation Club. Consensus from the 5th European Bifurcation Club meeting. EuroIntervention. 2010;6:34-8.
3. Movahed MR. Major limitations of randomized clinical trials involving coronary artery bifurcation interventions: time for redesigning clinical trials by involving only true bifurcation lesions and using appropriate bifurcation classification. J Interv Cardiol. 2011;24:295-301.
4. Grundeken MJ, Stella PR, Wykrzykowska JJ. Why the provisional single-stent approach is not always the right strategy; arguments for the development of dedicated bifurcation devices. EuroIntervention. 2012;7:1249-53.
5. Onuma Y, Muller R, Ramcharitar S, van Geuns RJ, Louvard Y, Morel MA, Morice MC, Davis R, Kaplan AV, Lefevre T, Grube E, Serruys PW. Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions. EuroIntervention. 2008;3:546-52.
6. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, Fujii K, Takebayashi H, Yasuda T, Costa JR Jr, Tsuchiya Y, Jensen LO, Cristea E, Mehran R, Dangas GD, Iyer S, Collins M, Kreps EM, Colombo A, Stone GW, Leon MB, Moses JW. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol. 2005;46:599-605.
7. Foin N, Alegria-Barrero E, Torii R, Chan PH, Viceconte N, Davies JE, Di Mario C. Crush, culotte, T and protrusion: which 2-stent technique for treatment of true bifurcation lesions?-insights from in vitro experiments and micro-computed tomography. Circ J. 2013;77:73-80.
8. Magro M, Wykrzykowska J, Serruys PW, Simsek C, Nauta S, Lesiak M, Stanislawska K, Onuma Y, Regar E, van Domburg RT, Grajek S, Geuns RJ. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis. Catheter Cardiovasc Interv. 2011;77:798-806.
9. Agostoni P, Foley D, Lesiak M, Belkacemi A, Dens J, Kumsars I, Scott B, Oemrawsingh P, Dubois C, Garcia E, Lefevre T, Stella PR. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry. EuroIntervention. 2012;7:1293-300.
10. Grundeken MJ, Smits M, Harskamp RE, Damman P, Woudstra P, Hoorweg AJ, Baan J Jr, Arkenbout EK, Piek JJ, Vis MM, Henriques JP, Koch KT, Tijssen JG, de Winter RJ, Wykrzykowska JJ. Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions. Neth Heart J. 2012;20:439-46.
11. Grundeken MJ, Asgedom S, Damman P, Lesiak M, Norell MS, Garcia E, Bethencourt A, Woudstra P, Koch KT, Vis MM, Henriques JP, Onuma Y, Foley DP, Bartorelli AL, Stella PR, Tijssen JG, de Winter RJ, Wykrzykowska JJ. Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies. EuroIntervention. 2013;9:195-203.
12. Foin N, Viceconte N, Chan PH, Lindsay AC, Krams R, Di Mario C. Jailed side branches: fate of unapposed struts studied with 3D frequency-domain optical coherence tomography. J Cardiovasc Med (Hagerstown). 2011;12:581-2.
13. Grundeken MJ, Agostoni P, Lesiak M, Koch KT, Voskuil M, de Winter RJ, Wykrzykowska JJ, Stella PR. Placement of Tryton Side Branch Stent only; a new treatment strategy for Medina 0, 0, 1 coronary bifurcation lesions. Catheter Cardiovasc Interv. 2013;82:E395-402.
14. Medina A, Suarez de Lezo J, Pan M. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol. 2006;59:183.
15. Gomez-Lara J, Brugaletta S, Farooq V, Onuma Y, Diletti R, Windecker S, Thuesen L, McClean D, Koolen J, Whitbourn R, Dudek D, Smits PC, Chevalier B, Regar E, Veldhof S, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography. JACC Cardiovasc Interv. 2011;4:1271-80.
16. Gomez-Lara J, Brugaletta S, Farooq V, van Geuns RJ, De Bruyne B, Windecker S, McClean D, Thuesen L, Dudek D, Koolen J, Whitbourn R, Smits PC, Chevalier B, Morel MA, Dorange C, Veldhof S, Rapoza R, Garcia-Garcia HM, Ormiston JA, Serruys PW. Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up. JACC Cardiovasc Interv. 2011;4:789-99.
17. Okamura T, Onuma Y, Garcia-Garcia HM, Regar E, Wykrzykowska JJ, Koolen J, Thuesen L, Windecker S, Whitbourn R, McClean DR, Ormiston JA, Serruys PW; ABSORB Cohort B Investigators. 3-dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification. JACC Cardiovasc Interv. 2010;3:836-44.
18. Okamura T, Onuma Y, Garcia-Garcia HM, Bruining N, Serruys PW. High-speed intracoronary optical frequency domain imaging: implications for three-dimensional reconstruction and quantitative analysis. EuroIntervention. 2012;7:1216-26.
19. Gomez-Lara J, Diletti R, Brugaletta S, Onuma Y, Farooq V, Thuesen L, McClean D, Koolen J, Ormiston JA, Windecker S, Whitbourn R, Dudek D, Dorange C, Veldhof S, Rapoza R, Regar E, Garcia-Garcia HM, Serruys PW. Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study. EuroIntervention. 2012;8:214-24.
20. Grundeken MJ, Lesiak M, Asgedom S, Garcia E, Bethencourt A, Norell MS, Damman P, Woudstra P, Koch KT, Vis MM, Henriques JP, Tijssen JG, Onuma Y, Foley DP, Bartorelli AL, Stella PR, de Winter RJ, Wykrzykowska JJ. Clinical outcomes after final kissing balloon inflation compared with no final kissing balloon inflation in bifurcation lesions treated with a dedicated coronary bifurcation stent. Heart. 2014;100:479-86.
21. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899-907.
22. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, de Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol. 2011;58:1578-88.
23. Okamura T, Serruys PW, Regar E. Cardiovascular flashlight. The fate of bioresorbable struts located at a side branch ostium: serial three-dimensional optical coherence tomography assessment. Eur Heart J. 2010;31:2179.